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Analysis of human epigenetic regions for Forensics: The Azlan model 
 
Student: Ahmed Arslan1 
Supervisor: Marie Allen2 
 
Abstract  
DNA methylation plays quite an important role in the mammalian genomes absolute functions. With 
the advancement in the epigenetics, it has been shown that the DNA methylation is a variable factor 
with respect to the age, differentially present in different human tissue types and may also be 
influenced by different life styles.  We designed a project of forensic genetics, to identify the human 
soft tissues, based on the quantification of DNA methylation at specific genomic regions of different 
human tissues. We used bisulphite (pyro) sequencing to quantify the DNA methylation and confirmed 
that the regions are different with respect to their DNA methylation content. This approach may serve 
in the future, as a powerful forensic platform not only as an identification tool for tissues of unknown 
nature but also to predict age, gender of the donor and time of the crime scene.  
Keywords: DNA, DNA methylation, mammalian genome, epigenetics, pyrosequencing, forensic. 
 
Background  
A heritable change in the gene function that is not controlled by DNA sequence change is called 
epigenetic change or simply epigenetics. All somatic cells from an individual are identical genetically 
(except B and T cells*) but still all of them are distinctly different and purposely differentiate to 
perform a particular physiological function (Christenson et al. 2008). The vast variety of the cellular 
phenotypes are only made possible by the epigenetically controlled gene expression, which also plays 
an important role in the cellular differentiation. DNA methylation is a property of higher eukaryotes 
that has profound effects on a number of life processes. In methylation of DNA, the methyl- group is 
attached at C5 of a cytosine at a given double stranded DNA fragment. The methylation of DNA is 
the most studied epigenetic modification because of its important role in embryonic development, 
genomic imprinting, X-chromosome inactivation. Moreover, the epimutations have been linked to a 
number of human diseases as well (Webar et al. 2007).  
In an epigenome most of the methylation presents at specific sites rich in C and G contents. These 
unique DNA segments are present at transcription factor binding sites (promoters) known as CpG 
island (CGIs). These CGIs are evolutionary conserved at promoter regions whereas the rest of a 
mammalian genome is depleted from these regions due to frequent CpG to TpG transitions. 
*The B cells and T-cells are important for their role in the immune system particularly in the production of antibodies. For this reason, these  
cells are able to manipulate their genetic makeup. They rearrange different functional gene segments to produce a functional antibody (Faber 
2013).  
1 - Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden.                    
2   - Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.  
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The two important enzymes (TDG and MBD4) selectively removes the T:G mismatches resulted from 
the deamination of methylated cytosine from C to T.  
Under normal conditions it is thought that cells maintain CGIs in an unmethylated state prior to the 
DNA transcription (Jones et al 2002). Since it has been established that the methylation of CGIs is 
incompatible with the gene activity, still there are contradictory claims of higher DNA methylation at 
promoter regions. It has also been suggested that the promoter CpG methylation is a complex 
phenomenon when coupled with human aging. 
The DNA methylation has been proposed as a biomarker for the disease susceptibility, as the 
promoter hypermethylation has been observed in cancer cases (Christensen et al 2009). A cancer is an 
aging disease with the age dependent increase in the DNA methylation levels has been observed. So it 
has motivated the researchers to study the DNA methylation of the cancer cells. The locus specific 
increase in the methylation levels were observed in different cell types irrespective of their type and 
origin. This could also lead to a common hypothesis that there must be a similar mechanism 
governing this DNA methylation change in the different cell types. There are two possible 
explanations for it, one is the reduced maintenance fidelity of methyltransferases with aging and the 
second is the environmental affects on methylation over the time.  
Recently genome-wide DNA methylation studies have shown tissue specific patterns of DNA 
methylation (Christensen et al 2009). These studies precisely define the tissue specific methylation 
patterns but are unable to show the mechanism by which these epigenetic variations resulted 
(Christensen et al 2009).   
In forensic medicine, the tissue identification is very important to establish the case with respect to the 
donor of the sample of interest. For this purpose, there are a number of biological procedures (to 
process the information from the biological samples recovered from the crime scene) established. 
These procedures are based on either analysis of the DNA, RNA or protein. The DNA based 
identification procedures use highly polymorphic autosomal STR (short tandem repeat), SNP (single 
nucleotide polymorphism) and Y-STR profiling to identify the DNA donor. These procedures are 
advantageous and give precise forensic clues but there are also some drawbacks in the use of these 
procedures, for example the information must be compared with the DNA profiles already present in 
the investigative databases. If the profiles are not already present in the relevant database than these 
procedures are not very useful (Kayser and de Knijff 2011). The procedures, which are based on the 
identification of RNA, aim to identify the differentially expressed mRNA in different cells. These 
procedures suffer heavily due to the fact that mRNA is a very unstable molecule that degrades with 
time and may thus not be helpful for old samples (Frumkin et al. 2010).  The protein detection based 
assays have some advantages over the routinely used lab procedures but still they are not ideal for 
forensic analyses. This is because they are based on the enzymatic or immunological detection and 
proteins are less stable then DNA and tend to denature with time and temperature. These procedures 
are less informative when used for the detection of old or degraded samples.  
With the advancement in the -omic era, new data has been generated regarding different aspects of the 
human genome including the epigenome. As described earlier we have now established data that 
describes the presence of different DNA methylation patterns in different tissues. Based on this idea 
we have designed a study where we could be able to identify different human tissues while studying 
DNA methylation of a certain CpG regions. For this purpose, we used pyrosequencing technique to 
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quantify the DNA methylation. The pyrosequencing may also help in quantifying the DNA 
methylation of degraded DNA as conventionally pyrosequencing has been used for the sequencing of 
short DNA strands (50 to 200bp).  
The aim of this study was to evaluate the presence of different DNA methylation patterns present at 
specific genomic regions in different (studied) human tissues, namely blood, semen, saliva and 
epithelium. The reason to perform these analyses was to make a new platform where we could 
confidently distinguish between different unknown tissues based on the epigenetic patterns. This 
procedure might also help in forensic tissue identification of unknown origin in future.  
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Material and methods: 
DNA sampling and bisulphite conversion: 
To analyse the DNA methylation levels of different tissues, we collected the samples of different 
human tissues including blood, semen, saliva and epithelium from a number of individuals of 
different age groups, gender and ethnic backgrounds.  
The DNA was extracted by using Wizard DNA purification kit (Promega) according to the 
manufacturer’s recommendation, and the concentrations were standardised with nanodrop.  
The DNA was processed by bisulphite conversion with a commercially available kit (Epitech, Qiagen, 
Germany), which was reported elsewhere (Fraga and Esteller 2002), according to the manufacturers 
recommendations. Briefly, this procedure converts the unmethylated cytosine to uracil and the 
methylcytosine remains unchanged. So this change introduced by the bisulphite treatment in the DNA 
sequence helps in precise detection and quantification of the methylation status of a region at a single 
base pair resolution.  
The methylated DNA was amplified by using pyromark PCR kit (Qiagen) (Table 1). This kit consists 
of a pyromark mix with a tailor-made HotStart Polymerase that is recommended for the bisulphite 
treated DNA’s PCR and pyrosequencing procedures. The PCR conditions were provided by the 
manufacturer’s directions with annealing temperature of 56°C. The amplified products were run on a 
2% agarose gel for 25min at 90V.  
Table 1. Polymerase chain reaction ingredients used for a reaction setup.  
Ingredients Concentration Quantity  
PyroMark PCR Mix# 10x 12.5ul 
CoralLoad¤ 1x 2.5ul 
Primers (each) 10mM 0.5ul 
MQ water  8ul 
DNA +/- 50ng/ul 1ul 
# PyroMark PCR Mix contains the Hotstart Polymerase, dNTPs and MgCl2 (3mM). ¤ CoralLoad is a combination of different dyes namely gel 
loading, red and orange dye.  
The pyrosequencing was performed using the Q24 pyrosequencing machine (Pyrosequencing AB, 
Uppsala). Briefly, pyrosequencing is a sequencing procedure that is known as “sequencing by 
synthesis” which depends on the detection of a pyrophosphate by the enzyme (ATP sulfurylase) and 
subsequent production of an ATP when a nucleotide is added to a growing sequence (Ahmadian et al 
2006). Another enzyme converts the ATP into a light signal that is recorded by computer and hence 
the sequencing (Figure 1).  During the methylation analysis, the pyrosequencing machine measures 
the ratio between the C without methyl-group to the C with methyl-group present in the studied 
sequence. A Cytosine nucleotide that is not followed by G is unmethylated and converted to T after 
the PCR of bisulfide treatment of DNA. This data depict as a pyrogram with the percentage of 
methylation present at a certain CpG position. A typical pyrogram is shown in figure 2, the height of 
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the peak is proportional to the number of the nucleotides added. We stored and analysed all the data 
on an excel sheet. 
 
Figure 1: Pyrosequencing principle displayed. Pyrosequencing depends on a protein complex, which 
consists of DNA polymerase, Apyrase, sulfurylase and Luciferease.  Polymerase incorporates the 
dNTPs to the growing DNA strand, as a nucleotide added to the growing strand it releases a 
pyrophosphate. This pyrophosphate converts to an ATP molecule by Sulfurylase enzyme, another 
enzyme, luciferase, helps to convert this ATP molecule to a light signal.  In this manner a sequence of 
light signals with different wave lengths is recorded in real time as the DNA strand. 
 
 
Figure 2: A typical pyrogram is shown here, with the horizontal axis showing the sequencing segment 
whereas the vertical axis showing the strength of the signals.  
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Results: 
To identify the different unknown tissues on the basis of the DNA methylation, we selected a panel of 
markers that have previously been reported for their tissue, age, and gender methylation 
discrimination (Table 2). The table shows a panel of DNA markers with the DNA methylation 
patterns observed in different tissues and other aspects i.e. age, gender and population. We tested 
these markers for a number of (different) tissues and the results have shown the interesting findings 
for each of the locus studied. We have observed a marked different in the DNA methylation in a locus 
specific manner in a particular tissue type for each marker that we have used. For example, we have 
used PLSCR2 marker to observed blood specific increase in the DNA methylation as reported 
elsewhere (Fraser et al 2012). Likewise, we have used already reported TLE1, CALCA, LAMB1, 
HENMT1 markers for the saliva, age, blood and sperm specific DNA methylation fluctuation 
receptively, and observed a specific pattern for each marker. The results were analysed by plotting the 
DNA methylation quantity against a specific methylation site (figure 3-7)  and complied into the excel 
charts. 
 
 
Table 2: The panel of selected genes previously reported for their differential DNA methylation behaviour for different 
aspects. ‘YES’ shows the trait for which a particular marker was used / reported.  
Gene/Locus Blood Saliva Sperm Age Gender Population 
PLSCR2 
(Fraser et al 
2012) 
YES   YES   
TLE1 (Liu et 
al. 2010) 
YES YES   YES  
CALCA  
(Sarter et al. 
2005) 
   YES YES YES 
LAMB1 
(Christensen et 
al 2009) 
YES   YES   
HENMT1 
(Molaro et al. 
2011) 
  YES    
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Figure 3: The tissue specific methylation observed at the CACLA gene region, the blood samples 
showing more methylation at this site when compared to other studied sample types. (The x-axis 
using the number of methylation observed sites in the given sequence whereas the y-axis showing the 
%age methylation at each site).  
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(A) 
 
(B) 
 
Figure 4: (A) shows the inter-tissue DNA methylation differences, the blood samples have much more 
quantities of methylation at this gene (HENMT1). (B) The methylation pattern observed at this locus 
in different age groups. (A is a 50 years old Swedish male, B is 50 years old English female, C 30 
years old fin lady and D is a 30 years old Swedish man).   
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(A) 
 
 
 
(B) 
 
Figure 5: (A) Shows the DNA methylation difference at the LAMB1 locus when observed in two 
sperm samples from two individuals. (B) Shows the difference in the methylation of blood samples at 
this locus from different age and gander. (A is a 50 years old Swedish male, B is 50 years old English 
female, C 30 years old fin lady and D is a 30 years old Swedish man).   
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(A) 
 
 
(B) 
 
Figure 6: (A) The observed DNA methylation at TLE1 gene shown here in different blood samples 
from different age groups. (A is a 50 years old Swedish male, B is 50 years old English female, C 30 
years old fin lady and D is a 30 years old Swedish man).  (B) The inter-tissue methylation patterns 
observed at this locus shown with blood having higher levels of methylation when compared to other 
sample types. 
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Figure 7: The locus (PLSCR2) specific methylation observed in different tissue samples. The sperm 
sample clearly shows a higher methylation trend at this studied locus.  
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Discussion: 
The forensic medicine has advanced over the last few decades. Many new and advanced molecule 
detection procedures have been created. Some of them have advantages over other in tissue 
identification but still not a single procedure could be considered as an ideal procedure to detect all 
required data from a given forensic sample (Frumkin et al 2011). The protein detection based assays 
might not work properly well when performed on old or degraded samples, due to the difficulty in 
detection of the denatured protein(s) of interest. A few recently developed forensic systems are based 
on the detection of the RNA from the samples but these assays are also targeting a relatively unstable 
molecule (mRNA) (Haas et al. 2009).  We have considered the DNA methylation as a source of 
information to detect the age, gender and tissue types from a crime scene sample. Our method has two 
important aspects; one is to detect the variations of the locus specific DNA methylation of different 
tissues. The second edge of our procedure is the use of pyrosequencing in methylation profiling. The 
methylation results from the covalently bonded chemical (methyl-) groups to the DNA, which is not 
degraded with time as in the case of RNA and protein. Hence DNA methylation tends to remain 
constant over a period of time. The pyrosequencing as described earlier is working best when used to 
sequence a segment with a length less than 500bp. So if we have degraded forensic samples our 
procedure of tissue detection may still works.  
Also we have shown that a specific region of the human genome could have the methylation 
fluctuation for the age, gender or ethnicity, hence these regions could be used for the forensic 
analysis. We have used the DNA markers which were previously reported for a certain trait for a 
range of different traits, like for example, if a region is reported for an age specific methylation 
difference we tested it for the gender discrimination at the same time along with age specific 
methylation and observed if we could find any difference for this trait as well (Azlan model). The aim 
was to use less number of markers to get more types of information. The gene PLSCR2 is previously 
reported for its differential methylation with aging (Fraser et al. 2012), but when we have used this 
marker for tissue detection, we have found really interesting results (Figure 7). In this chart the sperm 
samples have more methylation patterns than rest of the studied tissues.  Likewise, TLE1 locus 
specific methylation is reported for gender discrimination (Liu et al 2010), and we have used it for 
different age groups and gender as well. (Figure 6-A) For different tissue samples we can clearly see a 
difference of methylation among them (Figure 6-B). The LAMB1 marker is reported for its 
methylation differentiation with age (Christensen et al 2009), whereas we used it for both blood and 
sperm samples and showed a difference of methylation exist with age in both type of samples (Figure 
5A-B). The HENMT1 is reported for its higher methylation trends in sperm tissue (Molaro et al 
2011), but we have observed a different pattern of DNA methylation at this locus of different tissue 
types (Figure 4-A). The male individuals have more methylation content at this locus when compared 
to female samples with their respective age groups (Figure 4-B). The CALCA is shown to have a 
difference in the methylation with respect to the age and gender (Sarter et al 2005) but confirmed a 
tissue level difference in the methylation as well in our results (Figure 3).  
The quality of this type of research is largely dependent on finding regions of methylation 
differentiation and testing them on a range of samples. The aim of this study was to further formulate 
a panel of markers that may be able to give a more comprehensive set of information by using less of 
them and help in in-depth forensic analysis. For the future, the need is to more refine these results by 
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gathering more information about the methylation differential regions. And we also wanted to sample 
different tissues from people who are alcoholic and smoking addicts, to investigate if we can be able 
to detect the different methylation patterns which are specific to these life styles?   
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Molecular Genomic explanation of human sudden cardiac arrest 
Ahmed Arslan 1 
Marie Allen 2 
 
Abstract 
Sudden cardiac death (SCD) is an unexpected causality resulted by cardiac malfunctioning over a 
short stretch of time (<1 hour). SCD accounts for nearly 325,000 deaths per year in the United States 
only; more deaths are attributable to SCD than any other kind of natural death. The development and 
function of the human heart is under strict control of gene networks. Any change in the functional 
sequence of these genes could potentially be fatal. We have observed recently two of such cases 
where abnormal human heart function leads to sudden cardiac arrest. We planned to conduct a study, 
based on the exome sequencing and analysis of DNA samples taken from the cases. The aim of this 
project was to detect the sequence variations (SNP and Indels) that are only present in the cases but 
not in the population; and also interpret the possible role of these variants in these deaths. We detected 
around 21 new SNPs and 17 Indels that might possibly be the cause of the SCD. We want to continue 
analysing this data to detect more previously unknown/unrelated cardiac loci for their potential role in 
these causalities and help in formulating genetic tests for SCD. 
Keywords: Sudden cardiac death, gene, exome sequencing, sequence variations, SNP, Indels, genetics tests.  
 
Background 
Sudden cardiac death (SCD) is an unexpected causality resulted by cardiac malfunctioning occurring 
for a short period (generally within 1 h of symptom onset) in a person with known or unknown 
cardiac disease (in our case its was known). Most of the times the SCD cases are related to cardiac 
arrhythmias (Sovari et al 2012).  
The coronary heart disease often leads to the sudden cardiac death and in developed world including 
the USA the SCD responsible of 50% of deaths by cardiovascular diseases (Douglas et al. 2012). 
SCD accounts for nearly 325,000 deaths per year in the United States only this means only 0.1% to 
0.2% of all US population is dead of SCD but still these numbers are more than lung cancer, breast 
cancer, or AIDS. The frequency of SCD in Western industrialized nations is similar to that in the 
United States. This represents an incidence of 0.1-0.2% per year in the adult population. SCD is often 
the first expression of CAD and is responsible for approximately 50% of deaths from CAD. The trend 
towards expending the numbers of SCD events in developing nations of the world is thought to reflect 
a change in their dietary and lifestyle habits in these nations. It has been estimated that SCD claims 
more than 7,000,000 lives per year worldwide (Sovari et al 2012) (Figure 1-A). 
1 – Student, Department of Genetics and Bioinformatics, Swedish University of Agricultural Sciences, Uppsala, Sweden.     
2 - Professor, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.  
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The sudden cardiac events might relate with age and also vary in gender in overall populations of the 
world. The SCD incidents among the coronary disease patients decreased with the age (Figure 1-B) 
and men suffering from coronary heart diseases are more prone to die than the women. This ratio is as 
high as 75% where women died 3 to 4 times less than men from sudden cardiac death. As the figure 
1-B, depicts the mortality rate is high in the child with the age of 0 to 6 months, for that of sudden 
infant death syndrome. The condition of unexpected death in infants with no medical history that 
could also includes SCD.  
The initial studies on SCD have shown that the most persons affected by the sudden cardiac events are 
those with young age from 1 to 13 and 14 to 21 years with percentages of 19% and 30% respectively 
(Neuspiel et al 1985). 
 
 
’ 
Figure 1: (A) Sudden cardiac deaths’ relation with the sudden cardiac events (B) The relation of age 
with the sudden cardiac arrest shown.  
The sudden cardiac arrests often related to the anatomical changes in the heart or in the heart related 
structures observed in the autopsy of the hearts of subjects. In nearly all of the cases it has been 
observed that the coronary plague morphology change and/or myocardial scars present. In the cases 
where heart conduction disturbances have seen the role of apoptosis also may participate in these SCD 
(James et al 1996). But these changes are almost the same as those with coronary heart disease so they 
might not safely represent the risk factor for the SCD (Douglas et al 2012).  
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Regular exercise can decrease the events of cardiac arrest in experiment models but vigorous exercise 
in the athletes on the other hand produces deaths at a rate of 1 in 12000 individuals (Mittleman et al 
1993). Annually 20 to 25 deaths reported in US athletes due to sudden cardiac events. But still the 
overall impact of physical activity on the sudden cardiac arrest is somewhat controversial; as in one 
such study that shown the 67% of the deaths results from the SCD when the subjects were in their 
inactive physical states (de Vreede et al 1997).  
The genetics play the major role in the development and properly functionality of body physiology. A 
strong relationship exists between DNA sequence alterations and disease aetiology. The stable 
genome is essential to produce a healthy physiology of a cell. Any change in the heritable information 
might lead to a disease condition.  
The development and function of the human heart is under strict control of gene networks. A change 
in the functional sequence of these genes could potentially lead to an individual’s death. In last four 
decades workers all over the world have stalked genetics knowledge of cardiovascular diseases 
(CVD). Both familial and non-familial approaches conducted to analyse the genetics bases of CVD 
that provided clues of genetic alterations in the patients with respect to the healthy populations 
(Morita et al 2008). These genetic alternations included the single nucleotide changes, telomere 
shorting, and copy number variation. Most of these CVD are termed as “complex phenotype” resulted 
from the interplay of environment and genes.  
Genetic variants those are deleterious are often disease causing and remain rare in a population hence 
the disease. Whereas the variants those beneficial and lead to an advantage are established rapidly in a 
population. There are two schools of thoughts regarding the disease causing ability of these variants. 
One is called common disease common variants; stands for low penetrance with high frequency of the 
common variants lay the genetic bases of a common disease in a given population. On the other hand 
the rare variants involved in the pathology of a common disease with their strong penetrance. These 
rare variants are being quantified for common cardiac phenotypes with the emergence of next 
generation sequencing techniques these days. This lead to the discovery of previous unknown rare 
variants data that could help in understands the genetic complexity in the background of cardiac 
diseases like CAD (Novelli et al 2010).   
The common cardiac abnormal phenotypes in patients are related with the presented genetic data for 
the cardiac diseases (Table 1). This data showing that there are more then one genes that have been 
involved in a particular disease; the reason for this fact might be that the complex genetics 
background of a particular disease. One gene could be involved in more then one disease types or one 
disease could be a result of variations in different genes. For example, according to this data, NXK2.5, 
associated with disease conditions like DiGeorge syndrome, HOS, Allagille syndrome where as many 
genes on the other hand are involved in the aetiology of the DiGeorge syndrome (Table 1).  
We have observed recently two of such cases of sudden cardiac arrest registered at Uppsala 
University hospital where abnormal human heart function leads to sudden cardiac arrest. Both cases 
had some type of heart problems in their lifetime and none of them have them in their family. At the 
time of their death they were normal and feeling no signs of disease. Their ECG  (electrocardiogram) 
recorded at the time of their death shown abnormally elevated ST-segment that helped in 
understanding the possible reason of their death. And also help in planning a genetics study to further 
evaluate the genetic bases of their death.  
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Table 1: Summery of genes involved in the cardiovascularpathy with respective phenotypes (Novelli 
et al 2010) 
 
 
 
Aim of the study:  
The aim was to establish better understanding towards the role of genetic variations in the SCD cases. 
We decided to perform a study in collaboration with a group of physicians at Uppsala University 
hospital; the study was based on the exome sequencing analysis of DNA samples taken from the two 
index cases and parents of the third case. The objective was to detect and interpret the sequence 
variations (SNP and Indels) that are only present in the cases but not in other population.  
 
 
 
 
18 
 
Report 2  
Material and methods: 
The DNA was extracted by whole blood sampling of cases using commercially available kit (Wizard 
DNA purification kit, Promega). The whole exome sequencing was performed on AB 
SOLiD™ (Applied Biosystems) at Uppsala Genome Centre (UGC) by their skilled workers. The 
sequencing data was analysed by custom made Perl program scripting at UGC, further SNP and data 
analysis was performed using publically available data bases like UCSC genome browser 
(http://genome.ucsc.edu/), Polyphen 2.0 (http://genetics.bwh.harvard.edu/pph2/), Sift database 
(http://sift.jcvi.org/), String (http://string-db.org/), SMART (http://smart.embl-heidelberg.de/) and 
softwares like IPA (http://www.ingenuity.com/products/pathways_analysis.html), Alamut 
(http://www.interactive-biosoftware.com/), MUpro (http://mupro.proteomics.ics.uci.edu/). 
A thorough literature survey was performed on genes those are recently published for their role in 
heart diseases. And this step was further extended systematically to include more genes by doing 
gene-gene, protein-protein in-silico interaction analysis. This work plan helped us not only in 
generating a comprehensive panel of genes (Table 2) but also to filter the genes with their more 
disease causing ability. 
Results:  
The results are saved in the exile sheet (supplementary data file), the sheet 1 contains all the genes 
those were found with interesting variants with possible substitutions in DNA level and protein levels. 
The disease causing ability is shown under the heading Polyphen and Sift, these headings represent 
the data collected from these databases for individual SNP/Variant. The genes functions, individuals 
in which these are present and the publications in which these genes reported were also noted. The rs 
numbers of all individual SNP were also noted (where available) with the exon number they are 
present and their prevalence was also noted.  
After that these variants were furthered filtered, and categorised according to their ability to cause 
disease and also those are only present in our cases but not in the rest of the population (Table 
2/supplementary data sheet 5). Hence, by doing this type of filtering we omitted all the SNPs that are 
present in the general population and also those show doubtful in silico results regarding to the ability 
to cause disease. The focus was to generate as much data as possible from the seq data of our cases 
with deleterious affects. The table 2 (below) shows genes that are previously reported for their role in 
the heart dysfunctions with nucleotide changes for each of them. These nucleotide changes are not 
previously reported and are only found in our data from these individuals.   
The sheet 2 of supplementary data contains the possible exonic deletions/insertions in the genes those 
were previously noted for their ability to cause heart defects. This sheet represents the names of the 
genes, the type of Indel (deletion or insertion), also the functions and disease association of these 
genes, the microRNA non-mediated decay (NMD); either the Indel responsible for NMD or not, 
subjects, exon number and so on. The possible affects of a amino acid variant on the protein stability 
was analysed by using MUpro database (Table 2), this platform known for predicting how single site 
amino acid change could affect the overall dynamics and stability of a protein.  
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Table 2: Newly discovered data set of single nucleotide variants in respective genes with in-silico 
results of their disease causing ability. (Symbols: 1 = index patient 1, 2 = index patient 2, 3 = father of 
the index patient 3, 4 = mother of the index patient 3) 
Gene Nucleotide 
Change 
Amino acid 
change 
(Amalut 
prediction) 
Protein 
Stability 
prediction 
(MUpro -
results) 
Individual Mutation 
Taster - 
prediction 
Polyphen / 
Sift 
prediction 
Reference  
ILF3 A1378G Highly 
conserved  
No results 1 Disease 
causing 
Possibly 
damaging 
Associated 
with MI 
(Yoshida et 
al. 2011) 
CUL7 T674G Highly 
conserved  
Decrease  1 Disease 
causing 
Probably 
damaging  
Association 
with 
experimental 
MI (Hassnik 
et al 2009) 
SRFBP1 C1244A Moderately 
conserved 
No results 1 Disease 
causing 
Probably 
damaging 
Cardiac 
gene 
regulator 
(Zhang X 
et al 2004) 
MAPK14 G557C Highly 
conserved 
Decrease  1 Disease 
causing 
Probably 
damaging 
Cardiac 
therapeutic 
potential 
(Yeghiazaria
ns Y et al 
2012) 
AKT1 A1255C Highly 
conserved  
Decrease  1 Disease 
causing 
Possibly 
damaging 
Developmen
tal heart 
defects 
(Chang et al. 
2011) 
ALOX12 A563C Highly 
conserved  
Decrease  1 Disease 
causing 
Probably 
damaging 
Risk factors 
for 
atherosclerot
ic plaque 
burden and 
CHD events 
(Burdon et 
al 2010) 
MMP2 T1676A Highly 
conserved  
Decrease  2 Disease 
causing 
Probably 
damaging 
Possible 
association 
with cardiac 
malfunctions 
(Mishra et 
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al. 2012) 
THBS4 T272G Highly 
conserved  
Decrease  2 Disease 
causing 
Probably 
damaging 
A direct 
influence 
heart 
function and 
to identify 
(Frolova et 
al 2012) 
ACACB T3514G Highly 
conserved  
Decrease  2 Disease 
causing 
Probably 
damaging 
SNP marker 
for LDLC 
(Ruano et al 
2010) 
ACVR2B A767T Moderately 
conserved  
No results  3 Disease 
causing 
Possibly 
damaging 
Associated 
with atrial, 
ventricular 
septal 
defects; (Ma 
L et al 2012) 
CASP3 A697G Moderately 
conserved  
Decrease  3 Disease 
causing 
Possibly 
damaging 
KD 
susceptibilit-
y 
(Tremoulet 
et al 2012) 
SHROOM3 G5035C Moderately 
conserved  
Decrease  3 Disease 
causing 
Probably 
damaging 
Heterotaxy-
spectrum 
cardiovascul
ar disorders 
(Tariq et al. 
2011) 
PTPLAD1 A350C Highly 
conserved  
Decrease  3 Disease 
causing 
Probably 
damaging 
Red blood 
cell 
differentiatio
n and other 
traits (Ding 
et al 2012) 
LMCD1 T818G Highly 
conserved  
Decrease  3 Disease 
causing 
Probably 
damaging 
Co-regulator 
for GATA4/ 
regulate 
hypertrophic 
process 
(Luosujärvi 
et al. 2012) 
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RYR3 G5963C Highly 
conserved  
Decrease  3 Disease 
causing 
Possibly 
damaging 
SNP 
associated 
with HF 
(Lynch et al 
2012) 
MYL2 T53G Highly 
conserved  
Decrease  3 Disease 
causing 
Probably 
damaging 
Role in 
ASDII 
(Posch et al 
2011) 
 
PTK2 G3C No data Decrease  4 No data Possibly 
damaging 
Contribute 
to sarcomere 
disorganizati
on in DCM 
 (Chu et al. 
2011) 
ZFHX3 G9453T Highly 
conserved  
No results  4 Disease 
causing 
Probably 
damaging 
Associated 
with atrial 
fibrillation 
(Onouchi et 
al. 2012) 
HIF1A A930C Highly 
conserved  
Decrease  4 Disease 
causing 
Probably 
damaging 
Association 
studied with 
ischemic 
stroke 
(Avdonina 
et al 2012) 
GNAI1 T380C Moderately 
conserved 
Decrease  4 Disease 
causing  
Possibly 
damaging 
Signalling in 
cardiomyopa
thy pathway 
(Arejian et 
al 2009)  
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Discussion:  
The role of genome stability in proper functioning of a cell is well established now. In last decade, the 
-omic research has advanced a lot with respect to the finding of genetic origins of diseases. With the 
advancement of next generation sequencing techniques it is now possible to sequence whole genome 
or a particular region of interest. The new data on the disease genetics has revealed previously 
unknown disease associated gene variants.  
Our result showing quite a few interesting new findings in the exome-seq data from these cases DNA. 
Our main aim was to generate variants data for individual cases (Table 2).  This genes set previously 
shown to be either involved or associated with heart malfunctions or development, as presented in the 
given table 2. These genes recently studied for their number of disease implications towards human 
heart. We now reporting the genetic variations that are not previously reported, these gene variants are 
new and unique to these cases only. Our analysis shows a substantial amount of evidence that these 
variants are quite deleterious.   
We used publically available databases, SNP predictors; SNP variants disease causing ability 
predictors, different gene-gene interaction software, and new variants affects prediction software (see 
material and methods). All these available bioinformatics tools utilised and results detected. These 
tools precisely predicted the affects of these variants with respect to these individual genes 
(Supplementary data). Recently we reported the two new variants in the coding region of the PKP2 
gene (Dahlgren et al 2011). This gene has previously published for its SNP association with the 
Arrhythmogenic right ventricle cardiomyopathy. This finding suggested the L366P and L560P 
variants of PKP2 gene in exon 4 and exon 7 (respectively) are pathogenic.   
The new variants found in our data are rare gene variants and with low penetrance; these variants are 
only present in the our data when compared with SNP data at NCBI, since these genes played role in 
different types of heart diseases (Table 2) and known to take part in the human heart development and 
proper functioning in healthy individuals, we think they might work in concert to play an important 
role in the aetiology of sudden cardiac arrest.  
Our results show different genes that involved in the heart pathology have new variants present only 
in our studied cases. And this is only possible with the inventions and gradual improvements in the 
sequencing platforms. This also shows the importance of a continuous approach to explore the 
complex genetic bases of SCD.  Our data is novel, unique and credible with respect to the disease 
aetiology and addition to the role of rare genetic variants in the pathology. We have evaluated this 
data at number of stages (DNA/Protein) and at number of bioinformatics platforms, and then 
suggested that this data might be important with reference to the SCD. And if evaluated further we 
might confirm the possible role of these variants in actual generation of sudden cardiac arrest events 
in studied cases. This is also possible to predict a genetic evaluation test for patients with cardiac 
diseases for their possibility of going to SCD based on these findings.  
Most of these variants could potentially affect the stability of their respective protein, as predicted by 
MUpro (online protein stability platform), and it would be very interesting if these finding confirmed 
on protein level studies, that should help in better understand towards the role of these variants in 
aetiology of SCD. Presently we are working to sequence the regions containing these variants to 
establish their presence in the cases, and to role out the possibility of a bioinformatics artefact.  
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